Investigation of a carbapenem-resistant Acinetobacter baumanniioutbreak in the surgical unit of a cardiac care center in Karachi, Pakistan

Moiz Ahmed Khan , Memon Ahson , Shaikh Khudabaksh , Basheer Victor , Palous Margaret , Habib Abeer Salim , Khan Wajid Ali , Sheraz Nassim , Ilyas Arsalan , Sohail Abrar Khan

Microbes & Immunity ›› 2026, Vol. 3 ›› Issue (2) : 025350089

PDF (1490KB)
Microbes & Immunity ›› 2026, Vol. 3 ›› Issue (2) :025350089 DOI: 10.36922/MI025350089
ORIGINAL RESEARCH ARTICLE
research-article
Investigation of a carbapenem-resistant Acinetobacter baumanniioutbreak in the surgical unit of a cardiac care center in Karachi, Pakistan
Author information +
History +
PDF (1490KB)

Abstract

Carbapenem-resistant Acinetobacter baumannii(CRAB) poses a significant threat in cardiac surgical units due to its ability to survive on surfaces, intrinsic multidrug resistance, and association with high morbidity and mortality. Between June 15 and June 30, 2025, a tertiary cardiac care center in Karachi, Pakistan, identified an unusual cluster of CRAB infections among post-operative cardiac surgery patients, prompting a systematic outbreak investigation. A  multidisciplinary outbreak response team conducted an investigation on July 1 and July 2, 2025. Cases were defined as patients developing laboratory-confirmed CRAB infections with onset ≥48  h after hospital admission and within 30 days of cardiac surgery. Active case finding included medical record review and surveillance cultures. Direct observations assessed hand hygiene compliance, personal protective equipment (PPE) use, and environmental cleaning using standardized checklists. Environmental surveillance cultures were obtained from high-touch surfaces in operating rooms (ORs) and intensive care units. Fingerprint cultures from 10 healthcare workers (five from each setting) were screened for CRAB colonization. Seven patients developed CRAB infections: four ventilator-associated pneumonias (VAPs), two central line-associated bloodstream infections (CLABSIs), and one surgical site infection. The median age was 67 years (range 58–74), and the male-to-female ratio was 6:1. Four patients (57.1%) died, of whom two had VAP and two had CLABSI. All isolates demonstrated identical resistance profiles, including resistance to carbapenems, β -lactams, fluoroquinolones, aminoglycosides, and trimethoprim–sulfamethoxazole, with susceptibility to tigecycline and minocycline. Environmental cultures were negative. Fingerprint cultures identified CRAB colonization on one OR technician’s hands, with a susceptibility profile matching patient isolates. Observational audits revealed suboptimal hand hygiene, inadequate environmental cleaning between procedures, and inadequate compliance with PPE protocols. Our investigation revealed healthcare worker hand colonization and lapses in infection control practices as the primary drivers of CRAB transmission and underscored the critical need for sustained, resource-appropriate infection control interventions and continuous vigilance to prevent multidrug-resistant organism outbreaks in similar healthcare environments.

Keywords

Outbreak investigation / Healthcare-associated infections / Infection control / Operating room hygiene / Carbapenem-resistant Acinetobacter baumannii

Cite this article

Download citation ▾
Moiz Ahmed Khan, Memon Ahson, Shaikh Khudabaksh, Basheer Victor, Palous Margaret, Habib Abeer Salim, Khan Wajid Ali, Sheraz Nassim, Ilyas Arsalan, Sohail Abrar Khan. Investigation of a carbapenem-resistant Acinetobacter baumanniioutbreak in the surgical unit of a cardiac care center in Karachi, Pakistan. Microbes & Immunity, 2026, 3(2): 025350089 DOI:10.36922/MI025350089

登录浏览全文

4963

注册一个新账户 忘记密码

Acknowledgments

None.

Funding

None.

Conflict of interest

The authors declare that they have no competing interests.

Author contributions

Conceptualization: Moiz Ahmed Khan, Ahson Memon, Khudabaksh Shaikh
Data curation: Victor Basheer, Margaret Palous, Wajid Ali Khan, Nassim Sheraz
Formal analysis: Moiz Ahmed Khan, Victor Basheer, Margaret Palous
Investigation: Victor Basheer, Margaret Palous Methodology: Moiz Ahmed Khan
Project administration: Moiz Ahmed Khan, Ahson Memon, Khudabaksh Shaikh, Abeer Salim Habib, Sohail Abrar Khan
Supervision: Moiz Ahmed Khan, Arsalan Ilyas
Validation: Moiz Ahmed Khan, Victor Basheer, Margaret Palous
Visualization: Moiz Ahmed Khan
Writing–original draft: Moiz Ahmed Khan
Writing–review & editing: Moiz Ahmed Khan, Abeer Salim Habib

Ethics approval and consent to participate

Ethical approval was not required for this outbreak investigation as it constituted routine public health surveillance activities conducted by the institutional Department of Infection Control for immediate outbreak response and infection control purposes. The investigation was conducted in accordance with standard infection control protocols and institutional guidelines. All patient data were handled confidentially and in compliance with institutional policies for outbreak investigation and reporting.

Consent for publication

Written informed consent for publication was not obtained from individual patients, as this investigation constituted a public health surveillance activity conducted for immediate outbreak control and infection prevention purposes. All data presented have been rigorously de-identified and aggregated to ensure complete patient anonymity, with no personal identifiers, protected health information, or identifiable clinical details included in the manuscript.This approach is in accordance with established ethical guidelines for public health practice and outbreak reporting, where the imperative for timely dissemination of findings to protect public health outweighs the requirement for individual consent, provided confidentiality is strictly maintained. The investigation was performed under the authority of the institutional Department of Infection Control and adhered to internal protocols for outbreak management and data reporting.

Availability of data

All data generated during the course of this project are included in the published article.

Further disclosure

The complete findings of this outbreak investigation were presented in full at the Medical Microbiology and Infectious Diseases Society of Pakistan scientific session during the 46th Annual Conference of the Pakistan Association of Pathologists. This manuscript has not been previously published, nor has it been uploaded to any preprint server.

References

[1]

World Health Organization . WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance. World Health Organization; 2024. Available from: https://www.who.int/publications/i/item/9789240093461 [Last accessed on 2025 Jul 19].

[2]

Kao HH , Peng CK , Sheu CC , et al.Mortality and ventilator dependence in critically ill patients with ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. J Microbiol Immunol Infect. 2023; 56(4): 822-832. doi: 10.1016/j.jmii.2023.0400

[3]

De Benedetto I , Lupia T , Shbaklo N , et al.Prognostic evaluation of Acinetobacter baumanniiventilator-associated pneumonia in COVID-19. Infez Med. 2022; 30(4): 570-576. doi: 10.53854/liim-3004-12

[4]

Wong SC , Chau PH , So SYC , et al.Control of healthcare-associated carbapenem-resistant Acinetobacter baumanniiby enhancement of infection control measures. Antibiotics (Basel). 2022; 11(8): 1076. doi: 10.3390/antibiotics11081076

[5]

Lee KH , Kim J , Lee JA , et al.Carbapenem-resistant Acinetobacter baumanniioutbreak in a COVID-19 isolation ward and successful outbreak control with infection control measures. Infect Chemother. 2024; 56(2): 222-229. doi: 10.3947/ic.2023.0091

[6]

Bianco A , Quirino A , Giordano M , et al.Control of carbapenem-resistant Acinetobacter baumanniioutbreak in an intensive care unit of a teaching hospital in Southern Italy. BMC Infect Dis. 2016; 16(1): 747. doi: 10.1186/s12879-016-2036-7

[7]

Weber DJ , Rutala WA , Miller MB , Huslage K , Sickbert-Bennett E . Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacterspecies. Am J Infect Control. 2010; 38(5 Suppl 1): S25-S33. doi: 10.1016/j.ajic.2010.0419

[8]

Abuzaid AA , Zaki M , Al Tarief H . Potential risk factors for surgical site infection after isolated coronary artery bypass grafting in a Bahrain cardiac centre: A retrospective, case-controlled study. Heart Views. 2015; 16(3): 79-84. doi: 10.4103/1995-705x.164457

[9]

Thom KA , Johnson JK , Lee MS , Harris AD . Environmental contamination because of multidrug-resistant Acinetobacter baumanniisurrounding colonized or infected patients. Am J Infect Control. 2011; 39(9): 711-715. doi: 10.1016/j.ajic.2010.0900

[10]

U.S. Centers for Disease Control and Prevention . Principles of Epidemiology: Lesson 6, Section 2. United States: Centers for Disease Control and Prevention; 2023. Available from: https://archive.cdc.gov/www_cdc_gov/csels/dsepd/ss1978/lesson6/section2.html [Last accessed on 2025 Jul 19].

[11]

Kong Y , Liu T , Zhang Y , Wang H , Lin H . Investigation of an outbreak of carbapenem resistant Acinetobacter baumanniiin an intensive care unit during the COVID-19 epidemic. Antimicrob Resist Infect Control. 2025; 14(1): 30. doi: 10.1186/s13756-025-01547-0

[12]

National Healthcare Safety Network (NHSN) . Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection). Centers for Disease Control and Prevention; 2026. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf [Last accessed on 2026 Jan 21].

[13]

National Healthcare Safety Network (NHSN) . Pneumonia (Ventilator-Associated [VAP]and Non-Ventilator Associated Pneumonia [PNEU]) Event. Centers for Disease Control and Prevention; 2026. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/6pscvapcurrent.pdf [Last accessed on 2026 Jan 21].

[14]

National Healthcare Safety Network (NHSN) . Surgical Site Infection Event (SSI). Centers for Disease Control and Prevention; 2026. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf [Last accessed on 2026 Jan 21].

[15]

Shaikh TG , Waseem S , Ahmed SH , Swed S , Hasan MM . Infectious disease surveillance system in Pakistan: Challenges and way forward. Trop Med Health. 2022; 50(1): 46. doi: 10.1186/s41182-022-00439-y

[16]

Clinical and Laboratory Standards Institute . Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 35 thed. Clinical and Laboratory Standards Institute; 2025. Available from: https://clsi.org/shop/standards/m100-ed35 [Last accessed on 2025 Jul 19].

[17]

Centers for Disease Control and Prevention . CDC LC Quick Learn: Using an EPI Curve to Determine Most Likely Period of Exposure. Centers for Disease Control and Prevention; 2026. Available from: https://www.cdc.gov/training/QuickLearns/exposure [Last accessed on 2026 Jan 21].

[18]

OYong K , Coelho L , Bancroft E , Terashita D . Health care-associated infection outbreak investigations in outpatient settings, Los Angeles County, California, USA, 2000-2012. Emerg Infect Dis. 2015; 21(8): 1317-1321. doi: 10.3201/eid2108.141251

[19]

Fouad H , Halim MMA , Algebaly HF , Elmallakh NA . Influence of handprint culture training on compliance of healthcare workers with hand hygiene. Interdiscip Perspect Infect Dis. 2018; 2018: 3727521. doi: 10.1155/2018/3727521

[20]

Kim T , Jeon EH , Hong YK , et al.Minocycline susceptibility of carbapenem-resistant Acinetobacter baumanniiblood isolates from a single center in Korea: Role of tetB in resistance. Infect Chemother. 2025; 57(1): 111-118. doi: 10.3947/ic.2024.0110

[21]

Seok H , Choi WS , Lee S , et al.What is the optimal antibiotic treatment strategy for carbapenem-resistant Acinetobacter baumannii(CRAB)? A multicentre study in Korea. J Glob Antimicrob Resist. 2021; 24: 429-439. doi: 10.1016/j.jgar.2021.0101

[22]

Zhou H , Sun X , Lyu S , et al.Evaluation of tigecycline utilization and trends in antibacterial resistance from 2018 to 2021 in a comprehensive teaching hospital in China. Infect Drug Resist. 2023; 16: 879-889. doi: 10.2147/idr.s395158

[23]

Centers for Disease Control and Prevention . Carbapenem-Resistant Acinetobacter baumannii (CRAB): An Urgent Public Health Threat in United States Healthcare Facilities. Centers for Disease Control and Prevention; 2021. Available from: https://arpsp.cdc.gov/story/cra-urgent-public-health-threat [Last accessed on 2025 Jul 19].

[24]

Atik TK , Atik B , Kilinç O , et al.Epidemiological evaluation of an Acinetobacter baumanniioutbreak observed at an intensive care unit. Saudi Med J. 2018; 39(8): 767-772. doi: 10.15537/smj.2018.8.22431

[25]

Rivera F , Reeme A , Graham MB , et al.Surveillance cultures following a regional outbreak of carbapenem-resistant Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2022; 43(4): 454-460. doi: 10.1017/ice.2021.162

[26]

Infection Prevention and Control (IPC) . Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities. World Health Organization; 2017. Available from: https://www.who.int/publications/i/item/guidelines-for-the-prevention-and-control-of-carbapenem-resistant-enterobacteriaceae-acinetobacter-baumannii-and-pseudomonas-aeruginosa-in-health-care-facilities [Last accessed on 2025 Jul 19].

[27]

Perveen S , Habib SS . Identifying constraints for hospital infection control management via Mckinsey 7s framework in Pakistan. Pak J Public Health. 2018; 7(4): 213-222. doi: 10.32413/pjph.v7i4.81

[28]

Ehsan A , Ehsan F , Hanif H . Infection control practices in public sector hospitals of Punjab: A critical analysis. BMJ Open Qual. 2024; 13(Suppl 2): e002380. doi: 10.1136/bmjoq-2023-002380

PDF (1490KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/